2022
DOI: 10.1016/j.egyr.2022.01.198
|View full text |Cite
|
Sign up to set email alerts
|

Addressing scale-up challenges and enhancement in performance of hydrogen-producing microbial electrolysis cell through electrode modifications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
19
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 78 publications
(20 citation statements)
references
References 180 publications
0
19
0
1
Order By: Relevance
“…Modification to improve the microbe-electrode interaction has been conducted on both MECs and MFCs [ 79 ]. Electrode and microbial modifications, cell immobilisation, and electrode material selection have been extensively researched [ 80 , 81 , 82 ]. Although hydrogels are not commonly used within MEC research, other microbe immobilisation methods are used [ 83 ].…”
Section: Hydrogels Used In Metsmentioning
confidence: 99%
“…Modification to improve the microbe-electrode interaction has been conducted on both MECs and MFCs [ 79 ]. Electrode and microbial modifications, cell immobilisation, and electrode material selection have been extensively researched [ 80 , 81 , 82 ]. Although hydrogels are not commonly used within MEC research, other microbe immobilisation methods are used [ 83 ].…”
Section: Hydrogels Used In Metsmentioning
confidence: 99%
“…The protons combine with the electrons in the cathode chamber to produce hydrogen gas. However, the production of bio-hydrogen at the cathode is an endothermic reaction and therefore requires an applied voltage (0.2–0.8 V) [ 14 ]. The applied voltage (power supply) for bio-hydrogen production at the MEC (0.2–0.9 V) is much lower than for water electrolysis (1.23–1.8 V).…”
Section: Microbial Electrolysis Cells (Mecs)mentioning
confidence: 99%
“…Employing the developmental scale instrument to manufacture commercials will prevent scaleup-related issues and save time and capital for the pharmaceutical industries. In fact, within continuous manufacturing, the quality of products can be continuously monitored and controlled by mounting suitable process analytical technology (PAT) tools [11,12]. Any discrepancies triggered during the continuous run do not require quarantine of the entire batch.…”
Section: Introductionmentioning
confidence: 99%